UPDATE: Citigroup Reiterates Illumina at Neutral on Valuation
January 07, 2013 at 13:09 PM EST
Citigroup maintained Illumina (NASDAQ: ILMN ) at Neutral with a $51 price target. Citigroup commented, "We expect the stock to be under pressure today as investors question the deal valuation/near-term $0.20 EPS dilution of the Verinata deal, the longer term impact of ILMN competing with its own customers (i.e.,
